Yonhap Infomax NewsAug 11, 2025
POSCO Future M shares surged 19.2% in a week as foreign investors bought heavily, with domestic license fee risks resolved after a key patent win over CAMX Power.
#YonhapInfomax #POSCOFutureM #PatentInvalidation #ForeignBuying #LicenseFee #CathodeMaterials #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=76517
POSCO Future M Shares Surge Sharply as License Uncertainty Resolved

POSCO Future M shares surged 19.2% in a week as foreign investors bought heavily, with domestic license fee risks resolved after a key patent win over CAMX Power.

Yonhap Infomax
Yonhap Infomax NewsApr 23, 2025
SK Bioscience secures victory in patent invalidation case against Moderna's mRNA technology, boosting its position in vaccine development and global competitiveness
#YonhapInfomax #SKBioscience #PatentInvalidation #Moderna #MRNATechnology #VaccineDevelopment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59907
SK Bioscience Wins Final Patent Invalidation Lawsuit Against Moderna's mRNA Technology

SK Bioscience secures victory in patent invalidation case against Moderna's mRNA technology, boosting its position in vaccine development and global competitiveness

Yonhap Infomax